Papers matching “clinical trial endpoints” 570
Not finding it? Sign in to also search OpenAlex live.
-
221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions2022 Open Forum Infectious Diseases article Medicine Clostridium difficile and Clostridium perfringens research Open access
Anne J Gonzales-Luna, Andrew M Skinner, Carolyn D. Alonso, Oliver A. Cornely, Kevin W. Garey, Dale N. Gerding, +12 more
0citations -
Standardising definitions, endpoints, and reporting parameters for clinical studies of stereotactic body radiation therapy in bone metastases: An international Delphi consensus
Shing Fung Lee, Henry C. Y. Wong, Eva Oldenburger, Srinivas Raman, Gustavo Nader Marta, Adrian W. Chan, +18 more
1citations -
The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategies2024 BMC Medical Research Methodology article Mathematics Statistical Methods in Clinical Trials Open access
Stefanie Schoenen, Nicole Maria Heussen, Johan Verbeeck, R.-D Hilgers
6citations -
Defining inclusion criteria and endpoints for clinical trials: a prospective cross‐sectional study in CRB1‐associated retinal dystrophies2021 Acta Ophthalmologica article Biochemistry, Genetics and Molecular Biology Retinal Development and Disorders Open access
Mays Talib, Mary J. van Schooneveld, Jan Wijnholds, Maria M. van Genderen, Nicoline Elisabeth Schalij-Delfos, Herman E. Talsma, +8 more
24citations -
Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B2020 Neurotherapeutics article Biochemistry, Genetics and Molecular Biology Genetics and Neurodevelopmental Disorders Open access
Matthijs D. Kruizinga, Rob G. J. A. Zuiker, Elif Sali, Marieke L. de Kam, Robert Jan Doll, Geert Jan Groeneveld, +2 more
13citations -
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent
Elise A. Olsen, Sean J Whittaker, Rein Willemze, Lauren C. Pinter‐Brown, Francine M. Foss, Larisa J. Geskin, +28 more
184citations -
Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter aortic valve replacement: The PROGRESS Trial
Philippe Généreux, Raj Makkar, Jeroen Joost Bax, Philippe Pîbarot, Brian R. Lindman, Heather K. Prince, +4 more
10citations -
Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity, heart rate and sleep in healthy children
Matthijs D. Kruizinga, N. van der Heide, Ahnjili Zhuparris, Yalçin Yavuz, Marieke L. de Kam, Frederik E. Stuurman, +2 more
23citations -
Adjuvant hepatic arterial infusion pump chemotherapy with floxuridine for patients with resectable colorectal liver metastases and a low clinical risk score: A randomized controlled trial—The PUMP trial.
Loubna Outmani, Florian Buisman, Wills F. Filipe, Karen Bolhuis, Leni van Doorn, Pascal Gabriël Doornebosch, +14 more
4citations -
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression2025 Clinical Journal of the American Society of Nephrology article Medicine Chronic Kidney Disease and Diabetes Open access
Tom Greene, Willem Collier, Benjamin Adam Haaland, Chong Zhang, Sunil V. Badve, Fernando Caravaca‐Fontán, +18 more
8citations -
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial
Thorsten Brenner, Annabell Skarabis, Stefan Josef Schaller, Thilo von Groote, Christian Putensen, Ulf Guenther, +45 more
6citations -
MR CLEAN-LATE, a multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands for late arrivals: study protocol for a randomized controlled trial
F.A.V. Pirson, Wouter H. Hinsenveld, Robert‐Jan B. Goldhoorn, Julie Staals, Inger R. de Ridder, Wim H. van Zwam, +9 more
61citations -
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment2026 Nature Biotechnology article Biochemistry, Genetics and Molecular Biology Genetics, Aging, and Longevity in Model Organisms Open access
Alex A. Zhavoronkov, Fedor Galkin, Shan Chen, Feng Ren, Alex Aliper, Mikhail O. Durymanov, +13 more
5citations